Bayer Stock Has Now Lost Almost 50% of Its Value Since Merger With Monsanto

Bayer’s purchase of Monsanto was originally seen as a smart one for the German company because of their similar business models based on GMO seeds and pesticides.

But now, after the company was just ordered to pay over $2 billion dollars to two cancer victims over the use of Roundup, the controversial Monsanto herbicide, Bayer is reeling, and stockholders are not happy to say the least.

The trial is the third such decision against Bayer and Monsanto since groundskeeper Dewayne Johnson won a similar case in August 2018, and it could open the floodgates for billions of dollars in more judgments against the company, as over 1,000 similar lawsuits are still pending.

Read Entire Article »

Go to Source
Author: Alexander Light

Advertisements

Comments